On the FDA's permitting of new drugs, economists who actually express a policy judgment (Friedman, Peltzman, Becker, and topic specialists) overwhelmingly favor liberalization, yet randomly surveyed economists are rather supportive of the current FDA—revealing a significant impasse between issue-expressive and random economists.
factualpending
Speaker
Dan KleinEvidence Quote
“there's a very significant impasse between the issue expressive economists if you will the so-called you might call them specialists”
Created: 6/16/2026, 2:03:33 PM
Your notes
Loading notes...